Invention Grant
- Patent Title: ERK-derived peptides and uses thereof
-
Application No.: US15022280Application Date: 2014-09-15
-
Publication No.: US09695402B2Publication Date: 2017-07-04
- Inventor: Rony Seger , Alexander Plotnikov
- Applicant: Yeda Research and Development Co. Ltd.
- Applicant Address: IL Rehovot
- Assignee: Yeda Research and Development Co. Ltd.
- Current Assignee: Yeda Research and Development Co. Ltd.
- Current Assignee Address: IL Rehovot
- International Application: PCT/IL2014/050822 WO 20140915
- International Announcement: WO2015/040609 WO 20150326
- Main IPC: A61K38/12
- IPC: A61K38/12 ; C12N9/12 ; A61K38/00
Abstract:
An isolated peptide being no longer than 20 amino acids comprising a sequence at least 95% homologous to the sequence GQLNHILGILGX1PX2QED (SEQ ID NO: 4), wherein X1 and X2 are any amino acid, the peptide being capable of preventing extracellular signal-regulated kinase1/2 (ERK) translocation into the nucleus.
Public/Granted literature
- US20160340655A1 ERK-DERIVED PEPTIDES AND USES THEREOF Public/Granted day:2016-11-24
Information query
IPC分类:
